Market Scenario:
A polyp is an abnormal growth of tissue projecting from a mucous membrane
commonly found in the colon, stomach, nose, ear, sinus, urinary bladder, uterus
etc. although they may occur elsewhere in the body where mucous membranes
exist. Most polyps
are benign or non-cancerous while a few are premalignant. Premalignant polyps
can be a trigger factors for cancer and in general, the larger a polyp, the
greater the risk of cancer, especially with pre-malignant polyps. Most polyps
have no symptoms and screening is the only reliable measure to detect them.
Symptoms when evident are irregular periods and vaginal bleeding in women,
dysmenorrhea, pain, diarrhoea, constipation, nausea, vomiting etc. depending on
the location of the polyp.
Screening
is the most important driver for the global polyp market. Polyp are the most
important risk factors for colon cancer and most colorectal cancers begin as a
polyp, a growth in the tissue that lines the inner surface of the colon or
rectum. A certain type of polyp known as an adenoma may have a higher risk of
becoming a cancer and colorectal cancer is the third most common type of
non-skin cancer in both men and women and is the second leading cause of cancer
death in the United States after lung cancer. The U.S. Department of Health and
Human Services estimates that in 2016, an estimated 134,490 people in the
United States were diagnosed with colorectal cancer and 49,190 people died from
contracting it.
The
market drivers for polyp market are increasing geriatric population, growing
screening, rising awareness and their potentially cancerous nature. The market
restraints are risks such as bleeding and infection during surgery, low
healthcare expenditure in developing regions, costs considerations especially
for minimally invasive surgeries, no symptoms of most polyps, personal or
family history of polyps etc.
Segments:
The
global polyps market has been segmented on the basis of stage, types,
diagnosis, surgery and end users.
Based on
stage, the market has been segmented as benign and pre-malignant.
Based on
types, the market has been segmented as digestive polyps, endometrial polyp,
cervical polyp, nasal polyps, laryngeal polyps and pre-malignant.
Based on
diagnosis, the market has been segmented as occult blood and stool test,
colonoscopy, sigmoidoscopy, double contrast barium enema, computed tomography
and others.
Based on
treatment, the market has been segmented as drugs which is further sub
segmented into hormonal drugs, pain killers and others and surgery which is
further sub segmented into polypectomy, minimally invasive surgery, colon and
rectum removal and others.
Based on
the end users, the market has been segmented as hospitals & clinics,
academic and research and others.
Regional
analysis:
The
Americas account for a significant market share owing to extensive use of
medications and high expenditure on the health care. Additionally, the fastest
uptake of new technology in the US drives the global polyps market. Also,
concentration of major research companies and cancer research sector in the
developed countries of this region is adding fuel to the market growth.
Europe is
the second largest market in the world due to high income and healthcare
penetration.
Asia
Pacific region is expected to grow rapidly and China and India are likely to
lead this market due to fast growing healthcare sector during the forecast
period.
Gulf
nations such as Saudi Arabia and the UAE are estimated to drive the Middle East
& African market. The African region is expected to witness a moderate
growth owing to poor economic and political conditions and poor healthcare
development.
Key
Players in the Global Polyps Market
Some of
key players profiled in the report are Millennium Surgical Corp., Black Smith
Surgical, B. Braun Melsungen AG, Medtronic, Cook Medical, Endo Pharmaceuticals
Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd., Novartis AG, Mylan
Inc., Sun Pharmaceuticals and others.
Detailed
Table of Contents:
1. Report
Prologue
2. Market
Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
3. Research
Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size
Estimation
4. Market
Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic
Indicators
4.6 Technology Trends
& Assessment
5. Market
Factor Analysis
…
Continued!
About US:
Market Research
Future (MRFR), enable customers to unravel the complexity of various industries
through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw
Research Reports (3R), Continuous-Feed Research (CFR), and Market Research
& Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email:
sales@marketresearchfuture.com